ArticleBMC cancer2025

Targeting CD276: a promising strategy for CAR-NK cell immunotherapy in human oral tongue squamous cell carcinoma.

Shiyuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.